Call Today: 800-716-5901
Contact us for free information or to start a free case review.
What is Fosamax?
Fosamax (alendronate) is a prescription drug used to treat and prevent a variety of bone related conditions. After Fosamax received FDA approval in 1995, its maker Merck aggressively promoted this drug for the prevention and treatment of bone injuries and diseases. This drug is currently approved to prevent and treat osteoporosis in men and post-menopausal women, to treat Paget''s disease of the bone, and to treat patients with cancer that has metastasized to the bone. American doctors wrote estimated 39 million Fosamax prescriptions in 2005 alone.
What you need to know
Fosamax has been shown to increase the risk of a rare but serious condition called osteonecrosis (ONJ ). This Fosamax side effect causes infection and eventual rotting of the jawbone, requiring long-term treatment or surgery. If you or a loved one has developed osteonecrosis while taking Fosamax, you may be able to seek compensation for your losses with the help of a qualified attorney. Please contact us to speak with an attorney who can answer your questions and determine the best way to protect your legal rights.
Medical Findings Link Fosamax to Osteonecrosis
Fosamax benefits limited
Some researchers believe that Fosamax''s ability to prevent bone fractures is limited at best. When taken for more than ten years, Fosamax can actually increase the risk of bone fractures by making the bones more dry and brittle. Doctors add that this medication can remain in the body for up to ten years after terminating treatment.
Fosamax and osteonecrosis
In December 2004, experts at the Long Island Jewish Medical Center established a positive link between a drug similar to osteonecrosis and Fosamax. These results, which appeared in the Journal of Oral and Maxillofacial Surgeons , prompted the FDA and Novartis to issue a warning about the risk of this serious condition. Additional research indicates that the risk of osteonecrosis appears to be a class affect, posing the risk of serious bone injury to patients who take any bisphosphonate, including Fosamax. Please see our section on osteonecrosis and Fosamax to learn more.
Fosamax litigation
In April 2006, product liability attorneys filed a lawsuit against Merck, alleging the defectiveness of Fosamax. The plaintiffs in this case contend that Merck had, and continues to, conceal Fosamax side effect risks from the public. Through this Florida Fosamax lawsuit, attorneys are seeking class action status , which would allow the suit to represent over ten million Fosamax users. Qualified attorneys across the nation are currently evaluating individual Fosamax cases to determine how to protect those who have been injured.
If you or a loved one has developed osteonecrosis after long-term use of Fosamax, you do not have to suffer in vain; there is a way to get help . Please contact us to speak with a caring and competent legal professional who can evaluate your case and determine the best way to get you the help you need. Our qualified attorneys offer a FREE consultation so that you can learn more about your rights before determining your course of action.
A new study suggests that women taking the osteoporosis drug Fosamax are twice as likely to develop a chronic heart condition known as atrial fibrillat...
A new lawsuit has been filed against Merck & Co. over its osteoporosis drug Fosamax. The suit claims the drug caused a Connecticut woman to suffer multiple stress fractures in her l...
A lawsuit filed in a Florida federal court is claiming that Merck, the maker of Fosamax, was negligent in promoting its popular osteoporosis drug.
According to the complaint, Merck knew that Fosamax was defective but continuously concealed i...
Copyright © 2001 - 2012 Online Lawyer Source | Legal Marketing Site Designed by eJustice
ATTORNEY ADVERTISEMENT—Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer.